NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000048966

Registered date:01/10/2022

A study to determine the optimal puncture site for endoscopic ultrasound-guided tissue sampling in anticipation of comprehensive genomic profiling for patients suspected of having pancreatic cancer.

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedpancreatic cancer
Date of first enrollment2022/10/01
Target sample size61
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)endoscopic ultrasound-guided tissue acquisition using TopGain 19-Gauge needle

Outcome(s)

Primary OutcomeSuccess rate of the NCC OncoPanel criteria for analysis in precheck of specimens obtained by endoscopic ultrasound-guided tissue acquisition from primary pancreatic lesion Success rate of the NCC OncoPanel criteria for analysis in precheck of specimens obtained by endoscopic ultrasound-guided tissue acquisition from metastatic lesions of pancreatic cancer
Secondary OutcomeSuccess rate of the NCC OncoPanel criteria for analysis in precheck of specimens obtained by endoscopic ultrasound-guided tissue acquisition from primary pancreatic lesion and/or metastatic lesions Technical success rate of endoscopic ultrasound-guided tissue acquisition with 19-gauge needle The rate of adverse events

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaTwo or more lesions in the pancreas that are suspicious for pancreatic cancer

Related Information

Contact

public contact
Name Susumu Hijioka
Address 5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan Japan 104-0045
Telephone 03-3542-2511
E-mail shijioka@ncc.go.jp
Affiliation National cancer center hospital Hepatobiliary and pancreatic oncology
scientific contact
Name Takuji Okusaka
Address 5-1-1, Tsukiji, Chuo-ku, Tokyo, Japan Japan
Telephone 03-3542-2511
E-mail tokusaka@ncc.go.jp
Affiliation National cancer center hospital Hepatobiliary and pancreatic oncology